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httpcense.Abstract Introduction: Positive pressure ventilation may potentially affect the heart in ARDS
patients with structurally normal hearts and maybe correlated with respiratory parameters.
Aim: We aimed at observing NT-proBNP, Troponin I and Troponin T levels in relation to respi-
ratory parameters and positive pressure ventilation during the ﬁrst week of ARDS (day 0, 2, 7).
Patients and methods: The study comprised 20 patients with mean age of 58.9 ± 20.69 years, 11
men vs. 9 women (p> 0.05). Inclusion criteria were any adult patient diagnosed to have ARDS
according to the criteria of the American–European Consensus Conference in 1994. Exclusion cri-
teria were any structural heart disease by echo, pulmonary embolism, atrial ﬁbrillation, renal insuf-
ﬁciency, age less than 18. All patients were placed on a lung protective ventilation strategy. Plasma
NT-proBNP, Troponin I and Troponin T were measured on day 0 and on day 2 and day 7 of ARDS
diagnosis. PH, PaCO2, PaO2, PaO2/FiO2 ratio, PEEP, PIP (peak airway pressure), Pmean, Pplat
(plateau pressure) and Ceff (effective compliance), RaW (airway resistance) were monitored daily.
Results: NT-proBNP was negatively correlated with PH on day 2 (p 0.008, r 0.53) and day 7
with (p 0.02, r 0.50). NT-proBNP was positively correlated with PEEP on day 2 (p 0.05, r 0.46)
and day 7 (p 0.035, r 0.48). NT-proBNP was negatively correlated with PaO2/FiO2 ratio on day 7
(p 0.0035, r 0.60). However, there was no signiﬁcant correlation between NT-proBNP and other
respiratory indices including PaCO2, HCO3, PaO2, SaO2, FiO2 (p> 0.05). Neither Troponin I
nor Troponin T showed any signiﬁcant correlation with any respiratory indices PH, PEEP,
PaO2/FiO2, PaCO2, HCO3, PaO2, SaO2, FiO2 at any day (p> 0.05). None of the cardiac markers
NT-proBNPP, Troponin I or Troponin T showed any signiﬁcant correlation with lung mechanics
parameters Cdyn, RaW, Ceff, PIP, Pplat, Pmean (p> 0.05)..eg (Y.S. Nassar).
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14 Y.S. Nassar et al.Conclusions: In patients with ARDS positive pressure ventilation may adversely affect the heart
as reﬂected by elevations of NT-proBNP. High NT-proBNP level was correlated with high PEEP,
low PH and low PaO2/FiO2 ratio while Trop T and Trop I did not show signiﬁcant correlations with
respiratory parameters. None of the cardiac markers NT-proBNP, Troponin I or Troponin T
showed any signiﬁcant correlation with lung mechanics parameters (Cdyn, RaW, Ceff, PIP, Pplat,
Pmean, p> 0.05) in ARDS patients with structurally normal hearts.
Although the increase in cardiac markers are insigniﬁcant, yet they point to the potentially harm-
ful role played by high PEEP, low PH and low PaO2/FiO2 ratio on the heart. Currently, no clinically
relevant conclusion can be drawn apart from the recommendation to attempt to lower PEEP and
shorten the duration of positive pressure ventilation, even in patients with structurally normal
hearts.
 2013 The Egyptian College of Critical Care Physicians. Production and hosting by Elsevier B.V.
Open access under CC BY-NC-ND license.Introduction
Studies have shown that cardiac injury may occur in ARDS pa-
tients with structurally normal hearts and this maybe correlated
with the underlying respiratory changes [25]. B-type natriuretic
peptide (BNP) and N-terminal brain natriuretic peptide
(NT-BNP) are amino acid hormones that are synthesized in
the ventricular myocardium and released into the bloodstream
primarily under conditions of ventricular dilatation and pres-
sure overload. Serumhalf-lives of theNTpeptides (NT-proANP
and NT-proBNP) are considerably longer than those of other
natriuretic peptides, resulting in plasma levels that are at least
5–15 times larger. Thus, they are less inﬂuenced by the condi-
tions under which the sample is drawn and may therefore be
more appropriate in critical care settings. Moreover, although
BNP and NT-proBNP have equal predictive values for heart
failure, the latter is probably more sensitive in predicting death.
Mueller et al. (2005) compared head to head the diagnostic accu-
racy of B-type natriuretic peptide (BNP) and the amino terminal
fragment of its precursor hormone (NT-proBNP) and showed
that BNP and NT-proBNP may be equally useful as an aid in
the diagnosis of CHF in short of breath patients presenting to
the emergency department [1]. According to the Canadian Car-
diovascular Society 2012, NT-proBNP is recommended to be
obtained to rule in acute heart failure if its symptoms are suspi-
cious (900 pg/mL if age 50–75 years, 1800 if age 75 years) or to
be ruled out if NT-proBNP <300 pg/mL.[32]
Aim of the study
To assess the levels of biomarkers of cardiac injury (NT-proB-
NP, Trop I and Trop T) and observe its relationship with
respiratory parameters and positive pressure ventilation during
the ﬁrst week of ARDS (days 0, 2 and 7).
Patients
We performed the study prospectively on 20 adult patients
admitted to Critical Care Medicine Department, Cairo Uni-
versity Hospital, who were diagnosed to have acute respiratory
distress syndrome (ARDS) from June 2008 until April 2009.
Inclusion criteria
Any adult patient diagnosed to have ARDS according to the
criteria of the American–European Consensus Conference in1994 in which the disease is to be conﬁrmed by the combina-
tion of following diagnostic criteria:
 An initiating clinical condition (e.g. sepsis, burns).
 Acute onset.
 Bilateral inﬁltrates documented by chest radiograph at end-
inspiratory position.
 Pulmonary artery wedge pressure 6 18 mmHg or absence
of clinical evidence of left atrial hypertension by
echocardiography.
 ARDS: PaO2/FiO2 ratio 6 200 in a stable state after the
patient has adapted to standardized ventilation (regardless
of the level of PEEP).
Exclusion criteria
 Congenital heart diseases.
 Ischemic heart disease.
 Cardiomyopathies.
 Chronic Cor pulmonale.
 Atrial ﬁbrillation.
 Pre-existent renal insufﬁciency.
 Pulmonary embolism.
Methods
All patients were subjected to full history taking, thorough
clinical examination and transthoracic echocardiography to
exclude structural heart diseases. All patients beneﬁted from
mechanical ventilation with Lung protective ventilation strat-
egy according to NHBLI ARDS Network Treatment Protocol.
Daily arterial blood gases were analyzed (PH, PaCO2, HCO3,
PaO2, SaO2, FiO2, PaO2/FiO2), and mechanical ventilatory
mechanics parameters were recorded: Positive End Expiratory
pressure (PEEP), effective compliance (Ceff), dynamic compli-
ance (Cdyn), airway resistance (RaW), peak inﬂation pressure
(PIP), Plateau pressure (Pplat), mean airway pressure (Pmean).
Cardiac markers N-terminal pro-brain natriuretic peptide
(NT-proBNP), cardiac Troponin I (Trop I) and Troponin T
(Trop T) plasma level measurement were taken on days 0, 2
and 7. Venous blood samples were collected in 10-ml vacutain-
ers containing heparin. The samples were centrifuged at 3000g
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determined by an electrochemiluminescence sandwich immu-
noassay with an Elecsys 2010 instrument. For the measure-
ment of Trop I and Trop T we used a sandwich
immunoassay test .The upper limit of normal for NT-proBNP
was set at 450 pg/ml. The upper limit of normal for Trop I was
set at 1.5 and 0.5 lg/l for Trop T.
The study protocol was approved by the institutional re-
view board at Cairo University, and written informed consent
to participate and publish data was obtained from all partici-
pating patients or ﬁrst degree relatives. This study was fully
supported by Ministry of Higher Education, Cairo University,
Critical Care Medicine Department.
Statistical methodology
The data collected were tabulated and analyzed by SPSS (sta-
tistical package for the social science software) statistical pack-
age version 11 on IBM compatible computer. Quantitative data
were expressed as mean and standard deviation (X + SD) and
analyzed by applying Student t-test for comparison of two
groups of normally distributed variables and Mann–Whitney
U test for non-normally distributed ones. ANOVA test for
analysis of variance (f-test) was used for comparison of more
than two groups of normally distributed variables; and Krus-
kal–Wallis test was used for comparison of more than two
groups of non-normally distributed variables. Qualitative data
were expressed as number and percentage (No. and %) and
analyzed by applying chi-square test. Pearson correlation (r)
was used to detect association between quantitative variables,Table 1 The mean values of Cardiac markers NT-proBNP, Trop I
Parameter Day 0 Day 2
NT-proBNP 8903.3 ± 12852.81 6083.55 ± 8467.88
Trop I 3.04 ± 7.72 2.2 ± 6.63
Trop T 0.33 ± 0.61 0.63 ± 1.51
Figure 1 NT-proBNP correlation with PH on daywhile spearman correlation was used to detect association
between qualitative and quantitative variables. All tests were
used as tests of signiﬁcance at p< 0.05 [26].
Results
Our total ARDS study group comprised 20 patients, 11 men
(55%) and 9 women (45%). Patients were with mean age of
58.9 (±20.69) years old. There was no signiﬁcant difference
between males and females as regard incidence of ARDS
(p> 0.05) Survivors were 7 (35%) patients who were success-
fully weaned and discharged from ICU while 13 (65%) pa-
tients died. Regarding the etiology of ARDS, 5 cases (25%)
were due to sepsis, 4 cases (20%) due to pneumonia, 3 cases
(15%) due to aspiration, 3 cases (15%) due to lung contusions
caused by road trafﬁc accidents RTA, 2 cases (10%) due to
drug overdose, 1 case (5%) due to burn, 1 case (5%) due to
pancreatitis and 1 case (5%) due to drowning.Cardiac markers levels
NT-proBNP mean values (pg/ml) were on day 0:
8903.3 ± 12852.81, on day 2: 6083.55 ± 8467.88 and on day
7: 9914.75 ± 12574.09. There was no signiﬁcant difference be-
tween the readings of the 3 days (p> 0.05).
Trop I mean values (lg/l) were (3.04 ± 7.72) on day 0,
(2.2 ± 6.63) on day 2 and (1.53 ± 4.44) on day 7. There was
no signiﬁcant difference between the readings of the three days
(p> 0.05)., Trop T.
Day 7 ANOVA p Value
9914.75 ± 12574.09 0.72 >0.05
1.53 ± 4.44 0.28 >0.05
0.5 ± 1.08 0.69 >0.05
2 (p 0.008, r 0.53) and day 7 (p 0.02, r 0.50).
Figure 2 NT-proBNP correlation with PEEP on day 2 (p 0.05, r 0.46) and day 7 (p 0.035, r 0.48).
Figure 3 NT-proBNP correlation with PO2/FiO2 on day 7 (p 0.0035, r 0.60).
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(0.63 ± 1.51) on day 2 and (0.5 ± 1.08) on day 7. There was
no signiﬁcant difference between the readings of the three days
(p> 0.05) (Table 1).
Cardiac markers correlation with respiratory parameters
NT-proBNP was inversely correlated with PH on day 2 (p
0.008, r 0.53) and day 7 with (p 0.02, r 0.50) (Fig. 1).
NT-proBNP was positively correlated with PEEP on day 2
(p 0.05, r 0.46) and day 7 (p 0.035, r 0.48) (Fig. 2).
NT-proBNP was inversely correlated with PaO2/FiO2 ratio
on day 7 (p 0.0035, r 0.60) (Fig. 3).
However, there was no signiﬁcant correlation on any day
between NT-proBNP and other respiratory indices including
PaCO2, HCO3, PaO2, SaO2, FiO2 (p> 0.05) (Table 2).Neither Trop I nor Trop T showed any signiﬁcant correla-
tion on any day with any respiratory indices PH, PEEP, PaO2/
FiO2, PaCO2, HCO3, PaO2, SaO2, FiO2 at any day (p> 0.05)
(Table 2).
None of the cardiac markers NT-proBNP, Trop I or Trop
T showed any signiﬁcant correlation on any day with lung
mechanics including Cdyn, Ceff, RaW, PIP, Pplat and Pmean
(p> 0.05) (Table 3).
Discussion
In recent years, BNP and NT-BNP measurements have been
used to assist in the diagnosis, treatment, and prognostication
of patients with heart failure, being amino acid hormones that
are synthesized in the ventricular myocardium and released
into the bloodstream primarily under conditions of ventricular
Table 3 NT-proBNP, Trop I and Trop T Lung mechanics.
Day Cdyn Ceﬀ RaW PIP Pplat P mean
NT-proBNP 0 r 0.04 0.33 0.13 0.04 0.09 0.15
p >0.05 >0.05 >0.05 >0.05 >0.05 >0.05
2 r 0.06 0.04 0.18 0.22 0.24 0.07
p >0.05 >0.05 >0.05 >0.05 >0.05 >0.05
7 r 0.27 0.03 0.13 0.19 0.13 0.34
p >0.05 >0.05 >0.05 >0.05 >0.05 >0.05
Trop I 0 r 0.09 0.23 0.21 0.14 0.03 0.024
p >0.05 >0.05 >0.05 >0.05 >0.05 >0.05
2 r 0.16 0.26 0.28 0.02 0.08 0.29
p >0.05 >0.05 >0.05 >0.05 >0.05 >0.05
7 r 0.29 0.34 0.1 0.01 0.02 0.41
p >0.05 >0.05 >0.05 >0.05 >0.05 >0.05
Trop T 0 r 0.5 0.16 0.32 0.2 0.1 0.02
p >0.05 >0.05 >0.05 >0.05 >0.05 >0.05
2 r 0.22 0.17 0.33 0.21 0.2 0.02
p >0.05 >0.05 >0.05 >0.05 >0.05 >0.05
7 r 0.36 0.06 0.49 0.34 0.37 0.13
p >0.05 >0.05 >0.05 >0.05 >0.05 >0.05
Table 2 NT-proBNP, Trop I and Trop T correlation with respiratory parameters.
Respiratory indices NT-proBNP NT-proBNP NT-proBNP
0 day 2 day 7 day
r p r p r p
PH 0.28 >0.05 0.53 0.008 0.50 0.02
PCO2 0.29 >0.05 0.06 >0.05 0.15 >0.05
HCO3 0.07 >0.05 0.24 >0.05 0.41 >0.05
PO2 0.19 >0.05 0.34 >0.05 0.06 >0.05
SaO2 0.49 <0.05 0.33 >0.05 0.03 >0.05
FiO2 0.25 >0.05 0.08 >0.05 0.03 >0.05
PEEP 0.20 >0.05 0.46 0.05 0.48 0.035
PO2/FiO2 ratio 0.13 >0.05 0.30 >0.05 0.60 0.0035
Trop I Trop I Trop I
0 day 2 day 7 day
r p r p r p
PH 0.33 >0.05 0.09 >0.05 0.06 >0.05
PCO2 0.03 >0.05 0.34 >0.05 0.20 >0.05
HCO3 0.17 >0.05 0.19 >0.05 0.14 >0.05
PO2 0.20 >0.05 0.1 >0.05 0.19 >0.05
SaO2 0.19 >0.05 0.09 >0.05 0.24 >0.05
FiO2 0.10 >0.05 0. 14 >0.05 0.17 >0.05
PEEP 0.17 >0.05 0.36 >0.05 0.16 >0.05
P/f Ratio 0.01 >0.05 0.02 >0.05 0.02 >0.05
Trop T Trop T Trop T
0 day 2 day 7 day
r p r p r p
PH 0.21 >0.05 0.34 >0.05 0.39 >0.05
PCO2 0.51 >0.05 0.5 >0.05 0.37 >0.05
PO2 0.09 >0.05 0.2 >0.05 0.09 >0.05
PEEP 0.21 >0.05 0.44 >0.05 0.41 >0.05
p/f ratio 0.1 >0.05 0.01 >0.05 0.12 >0.05
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and NT-BNP levels are also elevated in other critical disease
states and may have similar clinical utility [5]. Levitt et al.
(2008) showed that BNP levels drawn within 48 h of admissionto the ICU do not reliably distinguish acute lung injury (ALI)
or acute respiratory distress syndrome (ARDS) from cardio-
genic edema, and do not correlate with invasive hemodynamic
measurements [2] and Lin et al. (2010) showed that BNP con-
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vivors in patients with ARDS who have normal LVEF [3]. The
aim of our study was to monitor the levels of biomarkers of
cardiac injury (NT-proBNP, Trop I and Trop T) and observe
its relationship with respiratory parameters and positive pres-
sure ventilation during the ﬁrst week of ARDS (days 0, 2 and
7).
We found that NT-proBNP was negatively correlated with
PaO2/FiO2 ratio on day 7 (p 0.0035, r 0.60). Hypoxia may be
the direct stimulus for BNP and atrial natriuretic peptide
(ANP) [18]. Emanuel et al. (2007) found that, in patients with
severe sepsis and septic shock, patients with increasing clinical
evidence of global tissue hypoxia over the ﬁrst 72 h had signif-
icantly higher BNP levels with a signiﬁcant inverse correlation
of BNP with ScvO2 [19]. Mitaka et al. back in 1997 had previ-
ously reported moderately elevated BNP values in ARDS, yet
these BNP values have been shown to correlate with pulmon-
ary and systemic vascular resistance but not with the partial
pressure of arterial oxygen (PaO2) or the ratio of the partial
pressure of arterial oxygen to the fraction of inspired oxygen
(PaO2/FiO2) [25]. Yangjin et al. (2008), reported that PaO2/
FiO2 ratio were not different from survivors and non-survivors
[27]. Doyle et al. back in 1995 reported speciﬁcally that mortal-
ity is not correlated with severity of hypoxemia [28], and Nuck-
ton et al. (2002), also showed that the inﬂuence of respiratory
variables on outcome in ARDS has been debated [29].
In our study, NT-proBNP was positively correlated with
PEEP on day 2 (p 0.05, r 0.46) and day 7 (p 0.035, r 0.48). Vic-
tor et al. (2008) similarly showed that BNP was correlated with
PEEP in 23 patients with severe sepsis/septic shock who devel-
oped respiratory failure requiring mechanical ventilation [20].
Niall et al. (2005) found that PEEP is independently associated
with intensive care unit mortality in ARDS patients (p value
0.01), while neither the PIP nor the Pplat showed such an asso-
ciation [30].
Mechanical ventilation by itself was found to increase BNP
as suggested by Yaniv et al. (2006) who measured NT-proBNP
in 78 critically ill patients and found that patients who required
mechanical ventilation had higher NT-proBNP levels than
those who did not (2200 pg/mL vs. 700 pg/mL, p< 0.001)
[21]. Echocardiographic signs of right ventricular (RV) over-
load, e.g., RV dilatation, may be absent, particularly if PEEP
is used and causes relative hypovolaemia by reducing of ve-
nous return [22]. Cifc¸i et al. (2010) showed that CPAP therapy
in Obstructive sleep apnea syndrome does not increase serum
pro-BNP, CK, CK-MB, Troponin I, and AST levels [23].
While Tasci et al. (2006) showed that application of CPAP
in obstructive sleep apnea syndrome actually decreased NT-
proBNP levels signiﬁcantly [24].These positive pressure effects
are probably achieved through its transmission to intratho-
racic vessels and terminally impacting LV and RV preload
and afterloads.
Acute cor pulmonale and RV overload as a consequence of
increased pulmonary vascular resistance (PVR) is known to
occur in 60% of patients with ARDS submitted to conven-
tional mechanical ventilation without airway pressure limita-
tion and still in 25% of patients with ARDS submitted to
protective ventilatory support [6], which might cause BNP ele-
vation as it causes RV pressure overload [7]. Thierry et al.
(2006) showed that in ARDS patients without LV dysfunction,
BNP levels are more elevated in patients with acute cor pulmo-
nale than patients without cor pulmonale. Damaged lungs,which are responsible for BNP clearance, contribute to this ele-
vation [8,6,9–11]. Byung Hoon Park et al. (2011) showed that
in patients with ALI/ARDS, intraindividual NT-proBNP
changes correlated with RV Afterload, right-over-left ventric-
ular stroke work ratio percentage change, pulmonary vascular
resistance and RV ejection fraction following open lung ap-
proach (OLA), thereby serving as a potential marker for RV
dysfunction after OLA. Our ﬁndings of the Markedly high
NT-proBNP levels associated with ARDS, maybe attributable
to right ventricular overload due to increased pulmonary vas-
cular resistance and inefﬁcient alveolar recruitment or mechan-
ical ventilator strategies, the mean age and the high incidence
of sepsis among the patient population [33].
We found that none of the cardiac markers NT-proBNP,
Trop I or Trop T showed any signiﬁcant correlation with lung
mechanics including Cdyn, RaW, Ceff, PIP, Pplat and Pmean
(p> 0.05), but this ﬁnding did not differentiate between
responders to the mechanical ventilator strategy and those
who did not respond as Byung Hoon Park et al. (2011), who
showed that in patients with ALI/ARDS, intraindividual
NT-proBNP changes correlated with Pplat in non-responders
to open lung approach (OLA) [33].
Niall et al. (2005) measured Cdyn, RaW, Ceff, PIP, Pplat in
the ﬁrst week (days 1, 3 and 7) of ARDS and found no signif-
icant differences in all these variables through the ﬁrst week.
Yangjin et al. (2008) reported that compliance Ceff was not
different from survivors and non-survivors [30].
Our study demonstrated a negative correlation between
NT-proBNP and PH on day 2 (p 0.008, r 0.53) and on day
7 with (p 0.02, r 0.50). This is in agreement with Emanuel
et al., in his study on patients with severe sepsis and septic
shock, showed that higher BNP levels are associated with high-
er lactate levels [19]. Koen J. Hartemink et al. (2011) proved
that NT-proBNP mounted to 2917 pg/mL (627–70,000 pg/
mL) in sepsis vs. 264 pg/mL (44–3571 pg/mL) in sonseptoc pa-
tients. NT-proBNP was 3483 pg/mL (171–70,000 pg/mL) in
non-survivors as compared with 301 pg/mL (44–56,343 pg/
mL) in survivors (p 0.001). A high NT-proBNP plasma level
is an independent marker of systolic cardiac dysfunction, irre-
spective of ﬁlling status, and is a better predictor of ﬂuid non-
responsiveness in septic vs. non-septic, critically ill patients
[34]. Gong et al. (2005) has previously proved that arterial
pH <7.22 in the ﬁrst 24 h of ICU stay can adversely affect
the outcome of ARDS patients [31], and similarly Niall et al.
(2005) showed that late respiratory or metabolic acidosis is
one of the factors independently associated with intensive care
unit mortality in ARDS patients [30]. Ammann et al. (2003)
found that troponin elevation among patients with sepsis
and SIRS is common (36–85% of cases) and associated with
a worse prognosis [12]. Rudiger et al. (2006) found that the lev-
els of natriuretic peptides were elevated in patients with sepsis
(even with preserved LV systolic function) as those with
decompensated HF [13]. Tomaru Kit et al. (2002) has reported
elevated values for BNP and NT-proBNP in animal models
with endotoxemia [14].
Sepsis may be the major factor implicated in the elevations
of NT-proBNP in our study since is considered the most com-
mon cause of ARDS in our study. Sepsis is often associated
with cardiac dysfunction aside from neurohormonal activa-
tion, and is referred to as ‘‘septic cardiomyopathy’’ and biven-
tricular dilatation. Sepsis is also a complex model of
proinﬂammatory, anti-inﬂammatory, and apoptotic biomark-
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endotoxin, and interleukin-1b can be of cardiovascular origin
or can primarily modulate serum BNP concentrations
[15,16]. He et al. (1999) has shown enhanced gene expression
of BNP and pro-ANP following stimulation of cultured
cardiomyocytes with IL-1B and following stimulation with
members of IL-6-related family (i.e., cardioltreophin-1) [17],
and ﬁnally the volume resuscitation in sepsis itself may be
the cause of NT-proBNP elevation [35].
Our remarkably elevated levels of NT-proBNP without any
signiﬁcant elevations of cardiac troponins may be explained by
the underlying mechanism of elevation of the cardiac marker.
BNP is released in response to LV and RV pressure loads and
wall stresses, with such hemodynamic effects commonly pres-
ent in ARDS, while on the other hand, troponins are released
in the circulation after myocardial cell damage and cytosolic
rupture, which does not necessarily occur in ADRS.
Study limitations
The small sample size of the patients. Other monitoring meth-
ods in correlation were not available as invasive Swan Ganz
hemodynamic monitoring or myocardial perfusion imaging,
successive echocardiographic studies or assessment of alveolar
responses to recruitment and mechanical ventilator strategies
may have highlighted more objectively the magnitude of any
cardiac injury and its changing acute clinical impacts, espe-
cially on the right ventricular afterload.
Conclusions
 Cardiac affection with minimal myocardial injury may
occur in ARDS patients with structurally normal hearts,
as evidenced by elevation of cardiac markers NT-proBNP,
Toponin T and Troponin I.
 High NT-proBNP level is correlated with high PEEP, low
PH and low PaO2/FiO2 ratio while Trop T and Trop I
did not show signiﬁcant correlations with respiratory
parameters.
 None of the cardiac markers NT-proBNP, Troponin I or
Troponin T showed any signiﬁcant correlation with lung
mechanics parameters (Cdyn, Ceff, RaW, PIP, Pplat,
Pmean) in ARDS patients with structurally normal hearts.
 Although the increase in cardiac markers are insigniﬁcant,
yet they point to the potentially harmful role played by high
PEEP, low PH and low PaO2/FiO2 ratio on the heart. Cur-
rently, no clinically relevant conclusion can be drawn apart
from the recommendation to attempt to lower PEEP and
shorten the duration of positive pressure ventilation, even
in patients with structurally normal hearts.
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